nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Rifampicin—leprosy	0.239	0.548	CbGbCtD
Dantrolene—CYP3A4—Dapsone—leprosy	0.197	0.452	CbGbCtD
Dantrolene—Pericarditis—Thalidomide—leprosy	0.0307	0.0551	CcSEcCtD
Dantrolene—Intestinal obstruction—Thalidomide—leprosy	0.0195	0.0349	CcSEcCtD
Dantrolene—Pleural effusion—Thalidomide—leprosy	0.0173	0.0311	CcSEcCtD
Dantrolene—Muscular weakness—Dapsone—leprosy	0.0166	0.0298	CcSEcCtD
Dantrolene—Acne—Thalidomide—leprosy	0.0158	0.0283	CcSEcCtD
Dantrolene—Atrioventricular block—Thalidomide—leprosy	0.0137	0.0245	CcSEcCtD
Dantrolene—Aplastic anaemia—Thalidomide—leprosy	0.0125	0.0224	CcSEcCtD
Dantrolene—Lightheadedness—Thalidomide—leprosy	0.0119	0.0213	CcSEcCtD
Dantrolene—Pulmonary oedema—Thalidomide—leprosy	0.0118	0.0212	CcSEcCtD
Dantrolene—Erythema—Dapsone—leprosy	0.0113	0.0203	CcSEcCtD
Dantrolene—Thrombophlebitis—Thalidomide—leprosy	0.0111	0.02	CcSEcCtD
Dantrolene—Vision blurred—Dapsone—leprosy	0.0107	0.0192	CcSEcCtD
Dantrolene—Visual disturbance—Thalidomide—leprosy	0.0102	0.0182	CcSEcCtD
Dantrolene—Cardiac failure—Thalidomide—leprosy	0.00987	0.0177	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00963	0.0173	CcSEcCtD
Dantrolene—Pain in extremity—Thalidomide—leprosy	0.00963	0.0173	CcSEcCtD
Dantrolene—Diplopia—Thalidomide—leprosy	0.00963	0.0173	CcSEcCtD
Dantrolene—Tachycardia—Dapsone—leprosy	0.00903	0.0162	CcSEcCtD
Dantrolene—Muscular weakness—Thalidomide—leprosy	0.0085	0.0152	CcSEcCtD
Dantrolene—Insomnia—Dapsone—leprosy	0.00837	0.015	CcSEcCtD
Dantrolene—Dysphagia—Thalidomide—leprosy	0.00833	0.0149	CcSEcCtD
Dantrolene—Eosinophilia—Thalidomide—leprosy	0.00824	0.0148	CcSEcCtD
Dantrolene—Pollakiuria—Thalidomide—leprosy	0.00769	0.0138	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dapsone—leprosy	0.00756	0.0136	CcSEcCtD
Dantrolene—Drowsiness—Thalidomide—leprosy	0.00742	0.0133	CcSEcCtD
Dantrolene—Depression—Thalidomide—leprosy	0.0074	0.0133	CcSEcCtD
Dantrolene—Abdominal pain—Dapsone—leprosy	0.00731	0.0131	CcSEcCtD
Dantrolene—Body temperature increased—Dapsone—leprosy	0.00731	0.0131	CcSEcCtD
Dantrolene—Renal failure—Thalidomide—leprosy	0.0073	0.0131	CcSEcCtD
Dantrolene—Sweating—Thalidomide—leprosy	0.00712	0.0128	CcSEcCtD
Dantrolene—Haematuria—Thalidomide—leprosy	0.00708	0.0127	CcSEcCtD
Dantrolene—Hepatitis—Thalidomide—leprosy	0.00666	0.012	CcSEcCtD
Dantrolene—Visual impairment—Thalidomide—leprosy	0.00642	0.0115	CcSEcCtD
Dantrolene—Chills—Thalidomide—leprosy	0.00598	0.0107	CcSEcCtD
Dantrolene—Vomiting—Dapsone—leprosy	0.00588	0.0106	CcSEcCtD
Dantrolene—Headache—Dapsone—leprosy	0.00579	0.0104	CcSEcCtD
Dantrolene—Tension—Thalidomide—leprosy	0.00569	0.0102	CcSEcCtD
Dantrolene—Dysgeusia—Thalidomide—leprosy	0.00568	0.0102	CcSEcCtD
Dantrolene—Nervousness—Thalidomide—leprosy	0.00563	0.0101	CcSEcCtD
Dantrolene—Back pain—Thalidomide—leprosy	0.00561	0.0101	CcSEcCtD
Dantrolene—Nausea—Dapsone—leprosy	0.00549	0.00986	CcSEcCtD
Dantrolene—Vision blurred—Thalidomide—leprosy	0.00547	0.00981	CcSEcCtD
Dantrolene—Ill-defined disorder—Thalidomide—leprosy	0.00538	0.00966	CcSEcCtD
Dantrolene—Anaemia—Thalidomide—leprosy	0.00536	0.00962	CcSEcCtD
Dantrolene—Malaise—Thalidomide—leprosy	0.00523	0.00939	CcSEcCtD
Dantrolene—Leukopenia—Thalidomide—leprosy	0.00519	0.00932	CcSEcCtD
Dantrolene—Convulsion—Thalidomide—leprosy	0.00503	0.00902	CcSEcCtD
Dantrolene—Hypertension—Thalidomide—leprosy	0.00501	0.00899	CcSEcCtD
Dantrolene—Myalgia—Thalidomide—leprosy	0.00494	0.00886	CcSEcCtD
Dantrolene—Discomfort—Thalidomide—leprosy	0.00488	0.00876	CcSEcCtD
Dantrolene—Dry mouth—Thalidomide—leprosy	0.00483	0.00867	CcSEcCtD
Dantrolene—Confusional state—Thalidomide—leprosy	0.00477	0.00857	CcSEcCtD
Dantrolene—Thrombocytopenia—Thalidomide—leprosy	0.00464	0.00832	CcSEcCtD
Dantrolene—Tachycardia—Thalidomide—leprosy	0.00462	0.00829	CcSEcCtD
Dantrolene—Hyperhidrosis—Thalidomide—leprosy	0.00458	0.00821	CcSEcCtD
Dantrolene—Anorexia—Thalidomide—leprosy	0.00451	0.0081	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Thalidomide—leprosy	0.00431	0.00774	CcSEcCtD
Dantrolene—Insomnia—Thalidomide—leprosy	0.00428	0.00768	CcSEcCtD
Dantrolene—Somnolence—Thalidomide—leprosy	0.00421	0.00755	CcSEcCtD
Dantrolene—Dyspepsia—Thalidomide—leprosy	0.00417	0.00748	CcSEcCtD
Dantrolene—Decreased appetite—Thalidomide—leprosy	0.00412	0.00738	CcSEcCtD
Dantrolene—Fatigue—Thalidomide—leprosy	0.00408	0.00732	CcSEcCtD
Dantrolene—Constipation—Thalidomide—leprosy	0.00405	0.00726	CcSEcCtD
Dantrolene—Pain—Thalidomide—leprosy	0.00405	0.00726	CcSEcCtD
Dantrolene—Feeling abnormal—Thalidomide—leprosy	0.0039	0.007	CcSEcCtD
Dantrolene—Gastrointestinal pain—Thalidomide—leprosy	0.00387	0.00695	CcSEcCtD
Dantrolene—Urticaria—Thalidomide—leprosy	0.00376	0.00675	CcSEcCtD
Dantrolene—Abdominal pain—Thalidomide—leprosy	0.00374	0.00672	CcSEcCtD
Dantrolene—Body temperature increased—Thalidomide—leprosy	0.00374	0.00672	CcSEcCtD
Dantrolene—Hypersensitivity—Thalidomide—leprosy	0.00349	0.00626	CcSEcCtD
Dantrolene—Asthenia—Thalidomide—leprosy	0.0034	0.00609	CcSEcCtD
Dantrolene—Pruritus—Thalidomide—leprosy	0.00335	0.00601	CcSEcCtD
Dantrolene—Diarrhoea—Thalidomide—leprosy	0.00324	0.00581	CcSEcCtD
Dantrolene—Dizziness—Thalidomide—leprosy	0.00313	0.00562	CcSEcCtD
Dantrolene—Vomiting—Thalidomide—leprosy	0.00301	0.0054	CcSEcCtD
Dantrolene—Rash—Thalidomide—leprosy	0.00299	0.00536	CcSEcCtD
Dantrolene—Dermatitis—Thalidomide—leprosy	0.00298	0.00535	CcSEcCtD
Dantrolene—Headache—Thalidomide—leprosy	0.00297	0.00532	CcSEcCtD
Dantrolene—Nausea—Thalidomide—leprosy	0.00281	0.00505	CcSEcCtD
Dantrolene—RYR3—tendon—leprosy	0.00152	0.216	CbGeAlD
Dantrolene—RYR3—testis—leprosy	0.00126	0.179	CbGeAlD
Dantrolene—RYR3—nervous system—leprosy	0.00124	0.175	CbGeAlD
Dantrolene—RYR1—tendon—leprosy	0.00109	0.155	CbGeAlD
Dantrolene—RYR1—testis—leprosy	0.000904	0.128	CbGeAlD
Dantrolene—RYR1—nervous system—leprosy	0.000888	0.126	CbGeAlD
Dantrolene—CYP3A4—nervous system—leprosy	0.000154	0.0219	CbGeAlD
